Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia [0.03%]
自身免疫性骨软化症：一种新型的纤维囊素23相关低磷血症骨软化症
Yoshitomo Hoshino,Nobuaki Ito
Yoshitomo Hoshino
Background: Fibroblast growth factor 23 (FGF23)-related hypophosphatemic rickets/osteomalacia arises from excessive FGF23 activity, with X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) as the most com...
Correction: Time-dependent improvement of quality of life with teriparatide or alendronate therapy: a JOINT-05 sub-analysis [0.03%]
纠正：特立帕肽或阿仑膦酸治疗后生活质量的时间依赖性改善作用：JOINT-05的次级分析结果
Satoshi Mori,Shiro Tanaka,Tatsuhiko Kuroda et al.
Satoshi Mori et al.
Published Erratum
Journal of bone and mineral metabolism. 2026 Feb 13. DOI:10.1007/s00774-025-01637-4 2026
How postmenopausal osteoporosis influences epidemiology and clinical features of CRPS-1 [0.03%]
绝经后骨质疏松对CRPS-1流行病学及临床特征的影响
Massimo Varenna,Raffaele Di Taranto,Francesco Orsini et al.
Massimo Varenna et al.
Introduction: This study aimed to investigate the relationship between Osteoporosis (OP) and Complex Regional Pain Syndrome type 1 (CRPS-1), in the hypothesis that OP can influence the epidemiological and clinical feature...
Trends in the incidence of secondary hip fractures and osteoporosis treatment in Japan (FY2012-FY2023) [0.03%]
日本二次髋部骨折发病率及骨质疏松症治疗趋势（2012财年-2023财年）
Shinichi Nakatoh,Kenji Fujimori,Shigeyuki Ishii et al.
Shinichi Nakatoh et al.
Introduction: This study aimed to clarify trends in the incidence of secondary hip fractures and pharmacotherapy after primary fractures over time in Japan. ...
Response to the comment on: "Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis"-proposal to validate cocktail efficacy in female osteoblasts [0.03%]
关于“白藜芦醇、r- Irisin和trolox鸡尾酒以对抗骨关节炎和骨质疏松症中的成骨细胞代谢变化”的评论的回复-建议在女性成骨细胞中验证鸡尾酒疗效
Roberto Bonanni,Angela Falvino,Amarildo Smakaj et al.
Roberto Bonanni et al.
Association of serum magnesium levels and calcimimetic use: fractures and cardiovascular events in Japanese haemodialysis patients [0.03%]
日本血液透析患者中血清镁水平与钙敏化剂使用、骨折和心血管事件的关联性研究
Tomohiro Saito,Masahide Mizobuchi,Kiryu Yoshida et al.
Tomohiro Saito et al.
Introduction: Though low serum magnesium (Mg) levels are associated with adverse outcomes in patients on haemodialysis, the interaction with calcimimetics remains uncertain. We hypothesized a potential interaction between...
Response to the letter regarding "Low BMI and postoperative outcomes in elderly hip fracture patients: a Japanese nationwide database study" [0.03%]
关于“低体质指数与老年髋部骨折手术预后：日本全国数据库研究”的来信回复
Yu Mori,Kunio Tarasawa,Hidetatsu Tanaka et al.
Yu Mori et al.
The effects of sequential therapy using anti-resorptive agents after administering once-weekly teriparatide or twice-weekly teriparatide [0.03%]
使用特立帕肽单周剂或双周剂后序贯抗吸收药物治疗的效果
Hidehiro Matsumoto,Manabu Tsukamoto,Nobukazu Okimoto et al.
Hidehiro Matsumoto et al.
Introduction: Studies launched in Japan on once-weekly teriparatide (1/W-TPTD) and twice-weekly teriparatide (2/W-TPTD) are limited. Therefore, we examined the effects of sequential therapy using anti-resorptive agents af...
Shoichiro Tani
Shoichiro Tani
Skeletal stem cells (SSCs) underlie skeletal development, homeostasis, regeneration, and aging, yet their identities and functions are highly heterogeneous across anatomical sites and life stages. Mouse genetic studies have identified multi...
Comment on: "Trolox, r-irisin and resveratrol cocktail to counteract osteoblast metabolism alterations in osteoarthritis and osteoporosis"-proposal to validate cocktail efficacy in female osteoblasts [0.03%]
关于“白藜芦醇、r-irisin和trolox鸡尾酒以对抗骨关节炎和骨质疏松症中成骨细胞代谢的改变”的评论-建议在女性成骨细胞中验证鸡尾酒的有效性
Jianying Chen,Xianda Zheng,Rongrong Chen
Jianying Chen